Back to Journals » Clinical and Experimental Gastroenterology » Volume 9 » default
![](https://www.dovepress.com/cr_data/cache/journal_image/34/cope/thumb_100_1000_100.jpg)
Clinical and Experimental Gastroenterology
ISSN: 1178-7023
- View all (555)
- Volume 17, 2024 (22)
- Volume 16, 2023 (26)
- Volume 15, 2022 (20)
- Volume 14, 2021 (51)
- Volume 13, 2020 (59)
- Volume 12, 2019 (44)
- Volume 11, 2018 (47)
- Volume 10, 2017 (34)
- Volume 9, 2016 (38)
- Volume 8, 2015 (34)
- Volume 7, 2014 (46)
- Volume 6, 2013 (28)
- Volume 5, 2012 (23)
- Volume 4, 2011 (32)
- Volume 3, 2010 (26)
- Volume 2, 2009 (20)
- Volume 1, 2008 (5)
Archive: Volume 9, 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Absorption and safety of serum-derived bovine immunoglobulin/protein isolate in healthy adults
Shaw AL, Mathews DW, Hinkle JE, Petschow BW, Weaver EM, Detzel CJ, Klein GL, Bradshaw TP
Clinical and Experimental Gastroenterology 2016, 9:365-375
Published Date: 5 December 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
HCVerso1 and 2: faldaprevir with deleobuvir (BI 207127) and ribavirin for treatment-naïve patients with chronic hepatitis C virus genotype-1b infection
Sarrazin C, Castelli F, Andreone P, Buti M, Colombo M, Pol S, Calinas F, Puoti M, Olveira A, Shiffman M, Stern JO, Kukolj G, Roehrle M, Aslanyan S, Deng Q, Vinisko R, Mensa FJ, Nelson DR
Clinical and Experimental Gastroenterology 2016, 9:351-363
Published Date: 24 November 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Necrotizing pancreatitis: challenges and solutions
![](cr_data/cache/submission_images/s99000/99824/fig1_200_200_90.jpg)
Bendersky VA, Mallipeddi MK, Perez A, Pappas TN
Clinical and Experimental Gastroenterology 2016, 9:345-350
Published Date: 31 October 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Comparison of Glasgow-Blatchford score and full Rockall score systems to predict clinical outcomes in patients with upper gastrointestinal bleeding
Mokhtare M, Bozorgi V, Agah S, Nikkhah M, Faghihi AH, Boghratian AH, Shalbaf N, Khanlari A, Seifmanesh H
Clinical and Experimental Gastroenterology 2016, 9:337-343
Published Date: 31 October 2016
![Noteworthy comment: The authors present a comprehensive review of the available data related to pregnancy in the patient with inflammatory bowel disease.](assets/img/article_icons/noteworthy.png)
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Managing inflammatory bowel disease in pregnancy: current perspectives
Pinder M, Lummis K, Selinger CP
Clinical and Experimental Gastroenterology 2016, 9:325-335
Published Date: 14 October 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Systematic review: treatment pattern and clinical effectiveness and safety of pharmaceutical therapies for Crohn’s disease in Europe
Lelli F, Nuhoho S, Lee XY, Xu WW
Clinical and Experimental Gastroenterology 2016, 9:311-323
Published Date: 5 October 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Cigarette smoking adversely affects disease activity and disease-specific quality of life in patients with Crohn’s disease at a tertiary referral center
Quezada SM, Langenberg P, Cross RK
Clinical and Experimental Gastroenterology 2016, 9:307-310
Published Date: 22 September 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Splenosis involving the gastric fundus, a rare cause of massive upper gastrointestinal bleeding: a case report and review of the literature
![](cr_data/cache/submission_images/s91000/91835/figure_2_final_with_title_200_200_90.jpg)
Reinglas J, Perdrizet K, Ryan SE, Patel RV
Clinical and Experimental Gastroenterology 2016, 9:301-305
Published Date: 22 September 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Ineffective esophageal motility and the vagus: current challenges and future prospects
Chen JH
Clinical and Experimental Gastroenterology 2016, 9:291-299
Published Date: 20 September 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Managing eosinophilic esophagitis: challenges and solutions
Shah NA, Albert DM, Hall NM, Moawad FJ
Clinical and Experimental Gastroenterology 2016, 9:281-290
Published Date: 16 September 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Influence of Saccharomyces boulardii CNCM I-745 on the gut-associated immune system
Stier H, Bischoff SC
Clinical and Experimental Gastroenterology 2016, 9:269-279
Published Date: 13 September 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Self-management in patients with inflammatory bowel disease: strategies, outcomes, and integration into clinical care
Plevinsky JM, Greenley RN, Fishman LN
Clinical and Experimental Gastroenterology 2016, 9:259-267
Published Date: 23 August 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Acute left-sided colonic diverticulitis: clinical expressions, therapeutic insights, and role of computed tomography
Ambrosetti P
Clinical and Experimental Gastroenterology 2016, 9:249-257
Published Date: 18 August 2016
![Noteworthy comment: The authors provide a comprehensive review concerning the](assets/img/article_icons/noteworthy.png)
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Optimal delivery of follow-up care after surgery for Crohn’s disease: current perspectives
Campbell JP, Vaughn BP
Clinical and Experimental Gastroenterology 2016, 9:237-248
Published Date: 8 August 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Improving outcomes of refractory celiac disease – current and emerging treatment strategies
![](cr_data/cache/submission_images/s87000/87200/12_may_2016_figure 2_200_200_90.jpg)
Woodward J
Clinical and Experimental Gastroenterology 2016, 9:225-236
Published Date: 3 August 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
An update on antibody-based immunotherapies for Clostridium difficile infection
Hussack G, Tanha J
Clinical and Experimental Gastroenterology 2016, 9:209-224
Published Date: 1 August 2016
![Noteworthy comment: The authors provide a comprehensive, well-written overview of the current understanding of hereditary pancreatitis with emphasis on the pathophysiology and pathogenesis of these disease processes.](assets/img/article_icons/noteworthy.png)
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Hereditary pancreatitis: current perspectives
Raphael KL, Willingham FF
Clinical and Experimental Gastroenterology 2016, 9:197-207
Published Date: 26 July 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Translational and clinical perspectives on sphincter of Oddi dysfunction
Kyanam Kabir Baig KR, Wilcox CM
Clinical and Experimental Gastroenterology 2016, 9:191-195
Published Date: 28 July 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
How do patients’ clinical phenotype and the physiological mechanisms of the operations impact the choice of bariatric procedure?
Bächler T, le Roux CW, Bueter M
Clinical and Experimental Gastroenterology 2016, 9:181-189
Published Date: 22 July 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Safety of polyethylene glycol 3350 solution in chronic constipation: randomized, placebo-controlled trial
McGraw T
Clinical and Experimental Gastroenterology 2016, 9:173-180
Published Date: 15 July 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Proton pump inhibitors for the treatment of patients with erosive esophagitis and gastroesophageal reflux disease: current evidence and safety of dexlansoprazole
Mermelstein J, Mermelstein AC, Chait MM
Clinical and Experimental Gastroenterology 2016, 9:163-172
Published Date: 13 July 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Ferumoxytol versus placebo in iron deficiency anemia: efficacy, safety, and quality of life in patients with gastrointestinal disorders
Ford DC, Dahl NV, Strauss WE, Barish CF, Hetzel DJ, Bernard K, Li Z, Allen LF
Clinical and Experimental Gastroenterology 2016, 9:151-162
Published Date: 11 July 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Gastroesophageal reflux disease symptoms in the Greek general population: prevalence and risk factors
Spantideas N, Drosou E, Bougea A, Assimakopoulos D
Clinical and Experimental Gastroenterology 2016, 9:143-149
Published Date: 21 June 2016
![Noteworthy comment: The authors provide an excellent overview of the association of FODMAP and irritable bowel syndrome.](assets/img/article_icons/noteworthy.png)
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Efficacy of the low FODMAP diet for treating irritable bowel syndrome: the evidence to date
Nanayakkara WS, Skidmore PML, O’Brien L, Wilkinson TJ, Gearry RB
Clinical and Experimental Gastroenterology 2016, 9:131-142
Published Date: 17 June 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Rectal budesonide and mesalamine formulations in active ulcerative proctosigmoiditis: efficacy, tolerance, and treatment approach
Christophi GP, Rengarajan A, Ciorba MA
Clinical and Experimental Gastroenterology 2016, 9:125-130
Published Date: 19 May 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Recent developments in choledochoscopy: technical and clinical advances
Xu MM, Kahaleh M
Clinical and Experimental Gastroenterology 2016, 9:119-124
Published Date: 11 May 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Essential phospholipids in fatty liver: a scientific update
Gundermann KJ, Gundermann S, Drozdzik M, Mohan Prasad VG
Clinical and Experimental Gastroenterology 2016, 9:105-117
Published Date: 5 May 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Fecal calprotectin: a marker for clinical differentiation of microscopic colitis and irritable bowel syndrome
von Arnim U, Wex T, Ganzert C, Schulz C, Malfertheiner P
Clinical and Experimental Gastroenterology 2016, 9:97-103
Published Date: 21 April 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Automated image analysis in the study of collagenous colitis
![](cr_data/cache/submission_images/s101000/101219/figure_4_200_200_90.jpg)
Fiehn AM, Kristensson M, Engel U, Munck LK, Holck S, Engel PJH
Clinical and Experimental Gastroenterology 2016, 9:89-95
Published Date: 8 April 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Profile of acotiamide in the treatment of functional dyspepsia
Ueda M, Iwasaki E, Suzuki H
Clinical and Experimental Gastroenterology 2016, 9:83-88
Published Date: 6 April 2016
![Noteworthy comment: The authors present a comprehensive and timely review of the current literature regarding achalasia and its treatment.](assets/img/article_icons/noteworthy.png)
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Clinical management of achalasia: current state of the art
![](cr_data/cache/submission_images/s84000/84019/figure_1bc_200_200_90.jpg)
Krill JT, Naik RD, Vaezi MF
Clinical and Experimental Gastroenterology 2016, 9:71-82
Published Date: 4 April 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Recent insights into the molecular pathogenesis of Crohn's disease: a review of emerging therapeutic targets
Manuc TE, Manuc MM, Diculescu MM
Clinical and Experimental Gastroenterology 2016, 9:59-70
Published Date: 15 March 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
A systematic review of disease-related stigmatization in patients living with inflammatory bowel disease
Taft TH, Keefer L
Clinical and Experimental Gastroenterology 2016, 9:49-58
Published Date: 7 March 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Identifying factors associated with clinical success in patients treated with NASHA®/Dx injection for fecal incontinence
Franklin H, Barrett AC, Wolf R
Clinical and Experimental Gastroenterology 2016, 9:41-47
Published Date: 2 March 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Optimal management of collagenous colitis: a review
O’Toole A
Clinical and Experimental Gastroenterology 2016, 9:31-39
Published Date: 10 February 2016
![Noteworthy comment: This review provides the reader with a nice overview on the role and impact of fecal calprotectin measurement for the management, diagnosis and monitoring of patients with inflammatory bowel disease (IBD).](assets/img/article_icons/noteworthy.png)
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Fecal calprotectin in inflammatory bowel disease
Walsham NE, Sherwood RA
Clinical and Experimental Gastroenterology 2016, 9:21-29
Published Date: 28 January 2016
![Noteworthy comment: The authors present an excellent review about the evolution and role of electrical stimulation of the lower esophageal sphincter for GERD as a new technology that is likely to become more widely used in the future.](assets/img/article_icons/noteworthy.png)
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Electrical stimulation for gastroesophageal reflux disease: current state of the art
Kim SE, Soffer E
Clinical and Experimental Gastroenterology 2016, 9:11-19
Published Date: 14 January 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Untreated newly diagnosed essential hypertension is associated with nonalcoholic fatty liver disease in a population of a hypertensive center
Michopoulos S, Chouzouri VI, Manios ED, Grapsa E, Antoniou Z, Papadimitriou CA, Zakopoulos N, Dimopoulos AM
Clinical and Experimental Gastroenterology 2016, 9:1-9
Published Date: 13 January 2016